We can expand this support through broader congress strategies, peer‑to‑peer education programs, and delivering integrated medical affairs plans. We can also apply AI‑enabled workflows to support tasks such as content development, insight synthesis, and asset adaptation, while always maintaining scientific rigor.

Across all engagements, our integrated approach connects medical, creative, and technology expertise, with innovation applied thoughtfully and where it adds real value. This underpins our existing partnership with Novartis and establishes a strong foundation for what comes next.